Exercise training for patients pre-and postsurgically treated for non–small cell lung cancer: a systematic review and meta-analysis

HJ Ni, B Pudasaini, XT Yuan, HF Li… - Integrative cancer …, 2017 - journals.sagepub.com
Background. This meta-analysis examined the effects of exercise training on length of
hospital stay, postoperative complications, exercise capacity, 6-minute walking distance …

A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer

P Murray, K Franks, GG Hanna - The British journal of radiology, 2017 - academic.oup.com
Stereotactic ablative body radiotherapy (SABR) describes a radiotherapy (RT) technique
where high doses of radiation are precisely delivered to an extracranial target within the …

Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured'from postoperative recurrence?

K Sekihara, T Hishida, J Yoshida, T Oki… - European Journal of …, 2017 - academic.oup.com
OBJECTIVES Since survival after postoperative non-small-cell lung cancer (NSCLC)
recurrence is extremely poor, the long-term post-recurrence outcomes are not well …

Recurrence pattern of pathologic stage I lung adenocarcinoma with visceral pleural invasion

D Jiwangga, S Cho, K Kim, S Jheon - The Annals of Thoracic Surgery, 2017 - Elsevier
Background Visceral pleural invasion (VPI) is well known to be a poor prognostic factor in
lung adenocarcinoma. There were few studies reporting postoperative recurrence pattern in …

Survival and prognostic factors of non‐small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy

L Ma, B Qiu, J Zhang, QW Li, B Wang… - Cancer …, 2017 - Wiley Online Library
Background Locoregional recurrence remains the challenge for long‐term survival of non‐
small cell lung cancer (NSCLC) patients after radical surgery, and curative‐intent …

[HTML][HTML] Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer

E Kim, C Song, MY Kim, JS Kim - Radiation Oncology Journal, 2017 - ncbi.nlm.nih.gov
Purpose The outcomes and toxicities of locoregionally recurrent non-small-cell lung cancer
(NSCLC) patients treated with curative radiotherapy were evaluated in the modern era …

[HTML][HTML] Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non–small-cell Lung Cancer Developing After Surgery

S Nakamichi, H Horinouchi, T Asao, Y Goto… - Clinical Lung Cancer, 2017 - Elsevier
Background The optimal treatment strategy for locoregional recurrences developing after
surgical resection in patients with non–small-cell lung cancer (NSCLC) is yet to be clearly …

The era of checkpoint blockade in lung cancer: taking the brakes off the immune system

EK Moon, CJ Langer, SM Albelda - Annals of the American …, 2017 - atsjournals.org
Despite recent advances with targeted kinase inhibitors and better-tolerated chemotherapy,
the treatment of metastatic non–small-cell lung cancer remains suboptimal. One recent …

[HTML][HTML] Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma

J Luo, R Wang, B Han, J Zhang, H Zhao, W Fang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Methods A total of 136 stage I lung adenocarcinoma patients who experienced tumor
recurrence after completely resection were included in this study. To analysis the …

Matched-pair analysis of a multi-institutional cohort reveals that epidermal growth factor receptor mutation is not a risk factor for postoperative recurrence of lung …

Y Matsumura, H Suzuki, T Ohira, S Shiono, J Abe… - Lung Cancer, 2017 - Elsevier
Objective It is unclear whether epidermal growth factor receptor (EGFR) mutation status is a
risk factor for postoperative recurrence of surgically resected lung adenocarcinoma (ADC) …